Hunter HN,Fulton DB,Ganz T.,et al.The solution structure of hunman hepcidin,a peptide hormone with antimicrobial activity that is involved in iron uptake and hereditary hemochromatosis[J].J Biol Chem,2002,277(40):376597-376603.
[9]
Alkhateeb AA, Han B, Connor JR. Ferritin stimulates breast cancer cells through an iron-independent mechanism and is localized within tumor-associated macrophages[J]. Breast Cancer Res Treat,2013 ,137(3):733-744.
[10]
Alkhateeb AA and Connor JR. The significance of ferritin in cancer: Anti-oxidation, inflammation and tumorigenesis[J]. Biochim Biophys Acta, 2013,1836(2):245-254.
[11]
Kalousová M, Krechler T, Jáchymová M, et al. Ferritin as an independent mortality predictor in patients with pancreas cancer. Results of a pilot study[J]. Tumour Biol, 2012, 33(5): 1695-1700.
[12]
Kuvibidila S, Gauthier T, Warrier RP,et al. Increased levels of serum transferring receptor and serum transferring receptor/log ferritin ratios in men withprostate cancer and the implications for body-iron stores[J]. J Lab Clin Med,2004,144(4):176-182.
[13]
Richardson D.R. Iron and neoplasia: Serum transferrin receptor and ferritin in prostate cancer[J]. J Lab Clin Med,2004,144:173-175.
[14]
Ali MA, Akhmedkhanov A, Zeleniuch-Jaquotte A,et al. Reliability of serum iron, ferritin, nitrite, and association with risk of renal cancer in women[J]. Cancer Detect Prev, 2003,27(2):116-121.
[15]
Prutki M, Poljak-Blazi M, Jakopovic M,et al. Altered iron metabo
[16]
lism, transferring receptor 1 and ferritin in patients with colon cancer[J]. Cancer Lett,2006,238(2):188-196.
[17]
Carpagnano GE, Lacedonia D, Palladino GP,et al. Could exhaled ferritin and SOD be used as markers for lung cancer and prognosis prediction purposes?[J].Eur J Clin Invest, 2012, 42(5): 478-486.
[18]
Jézéquel P, Campion L, Spyratos F,et al. Validation of tumor-associated macrophage ferritin light chain as a prognostic biomarker in node-negative breast cancer tumors: A multicentric 2004 national PHRC study[J]. Int J Cancer,2012,131(2):426-437.
Sabbah EN, Kadouche J, Ellison D, et al. In vitro and in vivo comparison of DTPA-andDOTA-conjugated antiferritin monoclonal anbody for imaging andtherapy of pancreatic cancer[J]. Nucl Med Biol,2007,34(3):293-304.
